Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Clover Biopharmaceuticals
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China
September 11, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Clover Provides Updates on Business and R&D Pipeline Development
July 10, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China
May 23, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Clover Announces Corporate Updates and Full Year 2022 Financial Results
March 28, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China
February 19, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
UPDATE -- Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
February 14, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
February 13, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
January 15, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Tickers
DVAX
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
November 30, 2022
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Tickers
DVAX
Clover Provides Update on 2022 Corporate Milestones
October 09, 2022
From
Clover Biopharmaceuticals
Via
GlobeNewswire
Tickers
DVAX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.